Delivery Order SPE2DR25D3505-SPE2DR26F93C3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $36,129.49 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order was issued on November 14, 2025, with an ultimate completion date of November 17, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $21,787.79 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of October 23, 2025. This competitively awarded, firm fixed-price delivery order represents a direct purchase under AmerisourceBergen's existing contract vehicle with DLA. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Repatha is a prescription medication...
- The Defense Logistics Agency awarded a delivery order valued at $12,600.66 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of November 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $6,884.63 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of July 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply relationship with the...
- The Defense Logistics Agency awarded a delivery order valued at $18,803.69 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with performance in Conshohocken, Pennsylvania and completion targeted for October 23, 2025. This non-set-aside, competitively awarded delivery order employs firm fixed price terms and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. Repatha is a prescription...
- The Defense Logistics Agency awarded a delivery order valued at $16,968.74 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pens, with an ultimate completion date of November 4, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a single transaction under AmerisourceBergen's larger contract vehicle with DLA. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $34,401.14 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector medication, with an ultimate completion date of September 9, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation. The award was issued on September 8, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Repatha is a prescription medication...
- The Defense Logistics Agency awarded a $5,369.58 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors on October 17, 2025, with completion targeted for October 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Repatha is a PCSK9 inhibitor indicated for cholesterol management in patients with...
- The Defense Logistics Agency awarded a delivery order valued at $22,527.18 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors on October 15, 2025, with completion scheduled for October 16, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award issued through the company's existing indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order valued at $3,405.33 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price, competitively awarded delivery order was issued on September 25, 2025, with an ultimate completion date of September 26, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D3505Indefinite Delivery Contract
- SPE2DR25D3505-SPE2DR26F93C3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,099.77 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors on November 13, 2025, with completion scheduled for November 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small single-transaction order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to military healthcare systems worldwide. Repatha is a PCSK9 inhibitor used for cholesterol management, reflecting the breadth of therapeutic categories covered under the DLA's medical supply chain to support Defense Health Agency, U.S. Coast Guard, and other government healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.1k | 11/13/25 |